MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
NRSN — NeuroSense Therapeutics Ltd. Ordinary Shares
NasdaqNeuroSense Therapeutics Ltd. Ordinary Shares
$4.07
+0.04(+0.99%)
- O
- 4.03
- H
- 4.33
- L
- 3.94
- V
- 17.77K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About NRSN
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
IndustryCommon Stock
SectorNot available
IPO DateDec 9, 2021
Employees16
Stock ExchangeNasdaq
Ticker SymbolNRSN
Key Financial Statistics
| Market Cap | $7.46M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.25 - $7.50 |
| 52-Week Avg Volume | 233.0K |
| VWAP | $4.08 |
| Transactions | 593 |
| Total Recorded Bars | 1,210 days |